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Summary Two hundred and twenty-two women with advanced cancer of the breast were asked to complete
two previously validated self-assessment questionnaires (Hospital Anxiety and Depression Scale (HADS) and
the Rotterdam Symptom Checklist (RSCL) in order to determine the prevalence and persistence of affective
disorders in this group of patients. Fifty-six (27%) of 211 women who completed the HADS and 33 (22%) of
204 who completed the RSCL rated as probable cases of an anxiety state and/or depressive illness. One
hundred and fifty-five patients completed the questionnaires again 1-3 months later. Twenty-one (13%) were
persistently anxious or depressed as judged by the HADS compared with 14 (10%) on the RSCL. When both
questionnaires were considered together, approximately one third of patients had scores suggestive of an
affective disorder and in one third of these it was persistent. Only 30 patients (43% of cases) were detected as
'cases' by both questionnaires and this finding warrants further investigation.
There has been extensive investigation into the psychological
sequelae of early breast cancer and its treatment (Maguire et
al., 1978; Maguire et al., 1980; Morris et al., 1977; Robert et
al., 1972) but there are few data concerning the prevalence of
depression and anxiety in patients with advanced disease.
There is a need to determine the extent and severity of
affective disorder in patients receiving palliative treatment for
breast cancer and to find out whether such disorder is tran-
sient or warrants intervention.
Plumb and Holland (1981) reported that 20-30% ofpatients
admitted to hospital for the treatment of a variety of
advanced cancers developed clinically significant depression
and 15% had severe anxiety. In a study of 215 cancer
inpatients and outpatients Derogatis and co workers (1983)
found 47% met criteria for psychiatric disorder, and of these
13% had a major affective disorder, mainly depression. The
majority were described as suffering 'adjustment disorder'
that is a less severe form of mood disorder. In a number of
other studies (Bukberg et al., 1980; Craig & Abeloff, 1974;
Farber et al., 1982; Plumb & Holland, 1977) self report
questionnaires have been used to assess psychological mor-
bidity in heterogeneous cancer patient groups. Two such
questionnaires were deemed suitable for use for the present
study. The Hospital Anxiety and Depression Scale (HADS)
(Zigmond & Snaith, 1983) was designed to measure depres-
sion and anxiety in medical outpatients and avoids the use of
somatic symptoms, which may also be attributed to disease
and treatment. It has been shown to be a valid measure of
the severity of disorders of mood. The Rotterdam Symptom
Checklist (de Haes et al., 1990) was designed as a multi-
dimensional scale for use in quality of life assessment: it
contains a subscale of eight items relating to psychological
symptoms.
The authors validated these two questionnaires in a series
of 81 patients with advanced breast cancer (Hopwood et al.,
1991), to establish appropriate cut-off values for the
identification of 'cases' of affective disorder. Both question-
naires identified 75% of patients diagnosed as cases by a
psychiatric interview. The scales were able to correctly
identify one in evey two high scorers as a case and, although
this predictive power was high in relation to 'screening' for
affective disorder, it will inevitably mean that prevalence
rates using self-rating scales are an estimate of morbidity
rather than an accurate measure of disorder. Nevertheless,
scales such as the HADS and RSCL are being used increas-
ingly to evaluate 'quality of life' in cancer patients and their
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performance in the measurement of psychological disorder in
a homogeneous population of patients warrants evaluation.
The aim of the study reported here was to use these two
questionnaires to assess the prevalance of affective disorders
in a large outpatient sample of women with advanced breast
cancer. A second aim was to determine there was a change in
psychological morbidity with time and therefore patients
were reassessed after a period of 1-3 months.
Patients and methods
Two hundred and twenty-two consecutive patients with
advanced cancer of the breast attending two specialist Breast
Clinics were asked by a trained research nurse to complete
the HADS and RSCL. All patients had histologically or
radiologically proven advanced cancer of the breast and were
attending the clinic in order to be certain that the appropri-
ate palliative treatments were being used to control symp-
toms and the progression of the disease. One hundred and
twenty-seven (57%) patients were receiving endocrine
therapy, 48 (21%) were receiving chemotherapy and 47
(22%) were not on specific systemic treatment.
In the validation study a cut-off score of 11 was found to
be the optimum value for detecting 'cases' of depression and
anxiety using the respective subscales of the HADS. A score
of 11 was also the optimum threshold value using the
psychological complaints subscale of the RSCL. The
prevalence of the affective disorder was measured according
to whether a patient's score fell into one of two subgroups:
normal, or probable case of affective disorder. Using the
HADS scale an additional subgroup was also identified, since
a 'borderline affective disorder' group had been defined by its
authors using scores between 8 and 10.
The Research Nurse described the purpose of the study
and explained to patients how the questionnaires should be
completed. All patients were asked to complete the question-
naires again at their next hospital visit. The interval between
these assessments ranged between 4 and 12 weeks, and
patients were not approached earlier even if they had to
return early to the clinic. This decision was made so that
assessments would not be burdensome to patients, and so
that sufficient time had elapsed to allow for changes in
psychological status in the patient sample.
The physical symptom ratings on the RSCL were
examined to find out whether key symptoms of advanced
breast cancer contributed to psychological morbidity. A
similar analysis was carried out for performance status as
rated by the patients using the Rotterdam Checklist.
'." Macmillan Press Ltd., 1991 Br. J. Cancer (1991), 64, 349-352350 P. HOPWOOD et al.
Results
Of the 222 patients approached by the research nurse 214
(96%) agreed to participate. Two hundred and eleven (95%)
patients completed the HADS, and 204 (92%) completed the
RSCL and questionnaires for three (1%) patients were
incomplete.
Fifty-six (27%) patients who completed the HAD scale on
the first occasion had scores of 11 or more on either the
anxiety subscale, depression subscale, or both and were
judged to be probable cases of affective disorder. Eighteen
(9%) had an anxiety state, 18 (9%) were depressed and 18
had mixed anxiety and depression. A further 39 (18%)
patients had scores between 8 and 10 which is regarded as
borderline psychological illness (borderline anxiety: 35
patients; borderline depression: one; and borderline mixed
anxiety and depression: three patients). Results are shown in
Table I. Using the RSCL psychological complaints subscale,
44 patients (22%) were deemed to have an affective disorder.
This briefer subscale dose not distinguish between anxiety
and depression, and has not been used to identify borderline
affective disorder.
There was no significant difference in the prevalence of
psychological morbidity detected by each questionnaire (27%
HADS vs 22% RSCL). However, there was a considerable
difference in the make up of the groups of patients desig-
nated as cases, according to which questionnaire was used.
Only 30 of the 56 patients detected by the HADS as cases
were also identified by the RSCL and 14 additional patients
were deemed to be cases using the RSCL but normal using
the HADS. This gives a concordance in identifying cases of
43%. Seventy (33%) patients were deemed to have an
affective disorder when the high scorers identified by both
questionnaires were combined.
Two assessments
All patients who completed the first assessment were ap-
proached again, providing they were attending 1-3 months
later. Ten (5%) patients declined to participate further, the
most frequent reason being 'I feel too poorly'. None of these
were high scorers at the first assessment. Thirteen (6%)
patients died prior to repeating the questionnaires, of whom
five were 'cases' (i.e. high scorers) at the first assessment.
Four (2%) patients had missing data at follow up and 30
(15%) were outwith the time frame for the second assess-
ment. Overall 13 out of the 70 patients identified as 'cases' on
the first occasion were not able to repeat the assessment. One
hundred and fifty-five (73%) patients completed a second
HADS questionnaire and 146 (72%) repeated the RSCL.
Twenty-eight (18%) patients were deemed to be depressed
and/or anxious by the HAD scale and 25 (17%) by the
RSCL on the second occasion. There was no significant
difference in the prevalence between the two time points.
However, this overall view masked the changes that occur-
red in psychological well-being. Thirteen of 24 patients who
were deemed anxious at the first assessment became border-
line or well at the second assessment but a further 11 patients
who were well became cases (see Table II). Similar changes
were seen when the HADS depression subscale and the
RSCL psychological complaints subscale were analysed.
Eleven (7%) patients were persistently anxious and 10 (6%)
persistently depressed as judged by the HADS and 14 (10%)
had a persistent affective disorder as judged by the RSCL.
At the second assessment point, 14 patients were identified
as 'cases' by both the HAD scale and the RSCL. This
represented a 50% agreement in case detection between the
two questionnaires, and a modest improvement on the first
assessment. The psychological subscale ratings for both
questionnaires were compared across treatment groups
(endocrine, cytotoxic, or no specific systemic therapy), and
there was no significant difference in questionnaire scores for
any treatment type. The data were also analysed with respect
to response status, as defined by the four groups, complete
response, partial response, stable or progressive disease.
Table I Self-rated affective disorder on the first assessment using
the Hospital Anxiety and Depression Scale (HADS) (n = 211) and
Rotterdam Checklist for Cancer Patients (n = 204)
Cases Borderlines
(%) (%)
HADS
Total cases 56 (27) 39 (18)
Anxiety 18 (9) 35 (17)
Depression 19 (9) 1 (21)
Mixed anxiety/depression 19 (9) 3 (1)
Well 116 (55)
RCL
Total cases 44 (22) - -
Psychological scores on all three subscales failed to show a
positive correlation with response category (see Table IV).
In order to see whether patients ratings of symptoms (e.g.
pain or shortness of breath), or functional status, were con-
tributing to psychological morbidity, the relationships
between patients scores for physical and functional status on
the RSCL and their psychological scores on both question-
naires were compared using the Pearson Correlation
Coefficient. The relationship between pain and psychological
distress was not a strong one (see Table V) whereas impaired
functional status was significantly associated with psycho-
logical distress on both questionnaires. Shortness of breath
was correlated with depression scores, but not with anxiety,
as measured by the HAD scale. Overall, physical symptoms
and impairment tended to be more strongly associated with
depression than with anxiety.
Discussion
An important feature revealed by the concurrent use of two
questionnaires here was that they detected different groups of
'cases'. Some discrepancy between the two instruments was
expected but has not been previously described, since others
have reported the use of a single questionnaire (Bukberg et
al., 1980; Craig & Abeloff, 1974; Farber et al., 1982; Plumb
& Holland, 1977). A number of factors may account for this
lack of agreement. Firstly, although the positive predictive
value of each instrument is relatively good at 56% (RSCL)
and 49% (HADS) respectively, it is inevitable that true
'cases' (as identified by a psychiatric interview) are only
discriminated from other respondents with high scores about
50% of the time. A second contributory factor may be the
time reference period used by each questionnaire (HADS -
past week, RSCL - past few days). Thirdly, individual
patients may rate themselves differently according to the
semantics of the respective questionnaires. Thus, to rate as a
probable 'case' according to the RSCL, high scores for items
such as 'depressed', 'irritable', 'worrying', 'anxious', are
required. In contrast, the HADS relies on anhedonic aspects
of depression such as 'I feel cheerful', 'I still enjoy the things
I used to enjoy'. 'I still can laugh and see the funny side of
things' for which a negative response scores high. This war-
rants a more detailed analysis to establish, for instance,
which particular items best discriminate psychological mor-
bidity.
A similar discrepancy in identifying psychiatric illness has
been described by Dean et al. (1983) when comparing
different sets of diagnostic criteria (Wing et al., 1978a;
Spitzer et al., 1978) used with their respective psychiatric
interview schedules (Endicott & Spitzer, 1978; Wing et al.,
1978b). When the two diagnostic methods were compared,
only 61% of cases of psychiatric illness were identified by
both systems. Although both schemes reported similar case
rates of illness, the actual cases were frequently different.
Dean suggested that the use of different symptom items and
different periods of duration contributed to this discrepancy.
In the present study the prevalence of psychiatric illness
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Table II Comparison of number of patients with affective disorder at the first and
second assessments (HADS: n = 155, RSCL: n = 144, percentage in parenthesis)
A Anxiety (HADS)
2nd assessment
Well Borderline Case
(Score 0-7) (Score 8-10) (Score > 11)
Well
E (Score 0-7) 82 (53) 8 (5) 3 (2) 93
23 Borderline
i (Score 8-10) 19 (12) 12 (8) 7 (5) 38
Case
(Score > 11) 6 (4) 7 (4) 11 (7) 24
107 (69) 27 (17) 21 (14) 155
B Depression (HADS)
2nd assessment
Well Borderline Case
(Score 0-7) (Score 8-10) (Score > 11)
Well
t (Score 0-7) 106 (68) 10 (6) 4 (3) 120
Borderline C (Score 8-10) 4 (3) 5 (3) 3 (2) 12
>, Case
(Score > 11) 6 (4) 7 (5) 10 (6) 23
116 (75) 22 (14) 17 (11) 155 (100)
C Psychological complaints (RSCL)
2nd assessment
Well Case
(Score 0-10) (Score >11) Total
t Well
E (Score 0-10) 106 (74) 11 (7) 117 (81)
t Case
| (Score > I1) 13 (9) 14 (10) 27 (19)
^ Total 119 (83) 25 (17) 144 (100)
Table III Change in questionnaire scores for two self-assessments 1 -3
months apart
Unchanged Decreased Increased n
Anxiety (HADS) 29 81 45 P = 0.05* 155
Depression (HADS) 43 61 51 NS 155
Psychological (RSCL) 20 62 62 NS 144
complaints
*Wilcoxon matched pairs signed rank test.
Table IV Pearson Correlation Coefficients
association between psychological morbidity
treatment
showing negative
and response to
Response status
HAD scale - 0.0356
anxiety
Depression - 0.0752
RSCL
psychological
complaints - 0.0412
Table V Pearson Correlation Coefficients to show relationship between psychological ratings and
RSCL scores for pain, shortness or breath (SOB) and functional status (FS) on two assessment
occasions
Pain SOB FS
1st 2nd 1st 2nd 1st 2nd
HAD Scale
Anxiety NS NS NS NS P = 0.004 P = 0.042
Depression NS P = 0.001 P = 0.0001 P = 0.081 P = 0.0001 P = 0.0001
RSCL
Psychological NS P = 0.049 NS P = 0.034 P = 0.001 P = 0.017
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reported for early breast cancer (Maguire et al., 1978) but
higher than the estimated prevalence calculated by the
authors (Hopwood et al., 1991), on the basis of a psychiatric
interview. This probably reflects the limits of accuracy of the
scales, particularly their predictive power.
Our results are comparable to a small number of other
studies in which self-assessment methods were used. Craig
and Abeloff (1974), using a well-known scale (Symptom
Check List 90) among 30 oncology patients reported depres-
sion in 50% of patients and elevated anxiety in 30%. Farber
et al. (1982) using the same scale found a 40% prevalence of
depression in oncology outpatients. Plumb and Holland
(1977) reported 25% of patients moderately or severely
depressed using the Beck Depression Inventory and Buckberg
et al. (1980) using the same scale found that 36% patients
self-rated in the depressed range. The present study lies
within the range of morbidity found by others in the field
although others have not restricted themselves to a
homogeneous group of cancer patients and have used small
numbers, which may explain the variability in results.
Whilst it was encouraging to find that psychiatric disorder
was transient in the majority of patients, it was persistent in
one third and may have been higher if the attrition rate
between assessments had been lower. Sequential question-
naires given a month apart would help to identify patients
with persistent high scores, and they could then be inter-
viewed by a nurse trained in assessment skills. We thought it
would be helpful to identify those factors relating to disease
(e.g., pain, breathlessness) or treatment type that might in-
crease the risk of persistent psychiatric disorder. Our data
suggested that impaired functional status contributes
generally to psychological distress, but shortness of breath
was more specifically associated with depression than with
anxiety. Surprisingly, the relationship between pain and
psychological morbidity was less robust, yet this is more
usually associated with depression. It is possible that pain
and breathlessness had an effect when they were severe
enough to influence functional status but not when con-
sidered alone. Other symptoms such as fatigue also warrant
evaluation, to better understand the interplay of these effects.
We had expected chemotherapy to have a more negative
impact on psychological wellbeing than endocrine therapy,
but this was not revealed by our study. Our treatment groups
contained unequal numbers of patients however, and the
value of our analysis was therefore limited. In contrast to
earlier work by Baum and Priestman, we did not find that
patients who were responding to treatment fared better
psychologically. The patient sample in the present study was
a heterogeneous one in terms of cancer therapy and patients
were recruited at different stages of treatment, which may
have contributed to the different result. When examining the
psychological ratings for the 20% patients who died during
the study period there was a tendency for their scores to be
higher than those surviving, suggesting that progressive
disease was associated with more psychological symptoms,
but this did not achieve statistical significance.
Conclusion
Affective disorder may occur in up to one in four patients
with advanced cancer of the breast, and be persistent in one
third of these. Simple self-assessment questionnaires are a
practical way ofidentifying and monitoring the psychological
status of patients. Patients thus identified should be assessed
further by a nurse trained in psychological assessment skills,
so that intervention can be appropriately targeted.
These questionnaires are not yet sufficiently robust in their
psychometric properties to give precise prevalence rates and
further work is required to improve their performance in this
area.
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